Ad
related to: merck & co news
Search results
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: American Express,...
Zacks via Yahoo Finance· 2 days agoStocks recently featured in the blog include: American Express Co. AXP, Walmart Inc. WMT, Amazon.com...
The Zacks Analyst Blog Highlights Broadcom, Merck, Airbnb, ONEOK and PG&E
Zacks· 7 days agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Broadcom ...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 1 day agoBeyond 2030, the drugmaker expects to add radiopharmaceuticals, or hybrid radiation-emitting drugs,...
Lilly partners with Aktis, deepening radiopharma investment
BioPharma Dive via Yahoo Finance· 1 day agoAnd in 2023, Merck & Co’s venture arm participated in the company’s Series A extension, which raised...
AltruBio lands up to $225M after shift to immune drug research
BioPharma Dive via Yahoo Finance· 1 day agoThe Phase 2a study AltruBio currently has underway in ulcerative colitis should produce results in...
Lilly's Once-Weekly Insulin Top-Line Results Show Benefit
Medscape· 7 days agoEli Lilly has announced positive phase 3 topline results for its once-weekly insulin efsitora alfa...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via AOL· 6 days agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
Medicenna to Present Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming Sachs 10th Annual...
Digital Journal· 7 hours agoMedicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, announced today that it ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 11 hours agoGlobal Antibiotics Market Projected to Reach $49.6 Billion by 2027 PR Newswire BOSTON, May 22, 2024 Global Antibiotics Market, as forecasted by BCC Research, to Grow at a Compound Annual Growth Rate (CAGR) of 4.2% Through 2027 BOSTON, May 22, 2024
Forbion-backed biotech Progentos debuts with $65M for MS drug
BioPharma Dive via Yahoo Finance· 2 days agoProgentos says the money will go toward expanding its pipeline and pushing an experimental treatment...